Nichiko Pharma to acquire 33.4% stake of Korea's Aprogen
Published: 2010-10-25 06:56:00
Updated: 2010-10-25 06:56:00
Aprogen Inc, a Daejeon-based manufacturer of diagnostic pharmaceuticals and an affiliated company of Schnell Biopharmaceuticals, said on October 21 that Japan based Nichiiko Pharmaceutical plans to acquire 33.4 percent of its stake through a private-placement contract.
Under the agreement, Jap...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
